Coco Giulia

Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial.

Additional treatment with citicoline eyedrops to IOP-lowering treatment might reduce disease progression in patients with progressing glaucoma despite IOP ≤18 mm Hg.

Lifelong experience of modified osteo-odonto-keratoprosthesis implantation over 50 years.

MOOKP showed excellent long-term anatomical and functional survival rates. Visual acuity significantly improved as soon as 3 months postoperatively and remained unchanged in about two-thirds of patients throughout the entire follow-up.

Assessment of dry eye questionnaires in patients with and without glaucoma.

147 patients with a mean age of 65.8±12.5 years were included.

Exploring the relationship between accommodation and intraocular pressure: a systematic literature review and meta-analysis.

Accommodation has an impact on IOP measurements and, overall, determines IOP decrease in healthy individuals.

Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture.

Metastatic tumors to the iris generally originate from primary malignancies in the breast, lung, or skin (melanoma). Despite successful ocular treatment, life prognosis is poor.